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IntroductIon
Convergence insufficiency (CI) is a binocular vision anomaly 
which is characterized by decompensated near exophoria, 
a remote near point of convergence (NPC), and reduced 
positive fusional vergence (PFV) at near.1 CI has the highest 
prevalence (3–5% of the general population) among all 
binocular vision disorders, and therefore, it has been the subject 
of many studies in this field.2,3 CI is usually associated with 
multiple symptoms including eyestrain, headache, blurred 
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vision, diplopia, sleepiness, difficulty concentrating, and loss of 
comprehension during near-visual activities (especially reading), 
leading to impaired educational, occupational, and athletic 
performance and decreased quality of life.3,4 Therefore, timely 
diagnosis and management of this disorder is an important issue 
in binocular vision practice.5 Since assessment of symptoms 
is an essential component of the diagnosis and follow-up 
of CI patients,6 the Convergence Insufficiency Symptom 
Survey (CISS) was designed by the Convergence Insufficiency 
and Reading Study group in 1999.7 The first version of this 
questionnaire contained 13 questions. It was later revised to 
a 15-item questionnaire by increasing the number of response 
categories from 4 to 5, broadening the activities addressed to 
include all close work, and dividing one of the questions to two 
separate questions.8,9 For each questionnaire’s item, the patient 
chooses one of the five possible responses (never, infrequently, 
sometimes, fairly often, and always). Each answer is scored 
from 0 to 4, with 4 indicating the highest frequency of the 
symptom (always). The overall CISS score is the sum of the 
scores of all 15 items, ranging from 0 (completely asymptomatic) 
to 60 (completely symptomatic).1,10
This questionnaire is the first standard instrument that is able 
to measure the type and frequency of symptoms associated 
with CI.1,10 The validity and reliability of the revised CISS 
have been measured in a number of studies in different age 
ranges including schoolchildren aged 9–18 years and young 
adults aged 19–30 years.9-12 The revised CISS has also been 
translated into other languages.4,9 The results have shown that 
this is a reproducible and valid instrument with a high internal 
consistency to discriminate between healthy subjects and CI 
patients and to assess clinical changes during the treatment 
process.9-12 It has also been found that this instrument has an 
added value for the diagnosis of other non-strabismic binocular 
vision disorders as well as accommodative dysfunctions 
with symptoms similar to CI, including accommodative 
insufficiency.9,13,14 In addition to its clinical applications, the 
CISS is extensively used for research purposes and is a vital 
component of the studies of binocular vision symptomatology.1,4 
Despite its importance and widespread application, to the best 
of our knowledge, the Persian version of this questionnaire is 
not available. As many Iranian patients are not familiar with 
English, there are limitations for using this valuable instrument 
by the Iranian clinicians and researchers. The present study 
was therefore conducted to prepare the Persian version of the 
revised CISS and determine its validity and reliability.
methodS
Study design
This validation study of the Persian version of “revised CISS” 
was conducted in two stages: the translation process and 
validity/reliability assessment.
Translation procedure
The CISS (revised version, release year; 2003)11 was translated 
into two phases according to the International Quality of Life 
Assessment protocol15 during a 3‑month period from July to 
September 2018. In the first phase, forward translation was 
done by two experienced translators proficient in the Persian 
and English languages with experience in questionnaire 
translation (translators 1 and 2). The translators were asked to 
present a list of alternative suggestions for some words if needed. 
Then, the agreed Persian version was presented to two other 
translators who were skilled in Persian philology (translators 
3 and 4) to assess the quality of translation in terms of aspects 
such as clarity of the text, usage of the common language, and 
conceptual equivalence (similarity of content/meaning). In 
the second phase (backward translation), two native English 
translators (translators 5 and 6) were asked to translate the 
approved Persian version confirmed in phase one into English. 
Finally, the backward version, along with all reports, were 
assessed and finalized by researchers.
Sample size calculation
The sample size was calculated based on the Cronbach’s alpha 
index according to the Bonett’s formula.16 In this formula, k 
represents the number of items in the questionnaire (15). α 
and β are Types 1 and 2 errors which were considered 0.05 
and 0.1, respectively. CA0 indicates the value of Cronbach 
alpha at null hypothesis, which is considered the minimum 
acceptable value of 0.70, and CA1 is the expected value of 
the Cronbach’s alpha (0.92), which was extracted from one of 
the previous similar studies.11 With this manner, the required 
sample size was estimated at 29, which was rounded up to 
30 patients.
Study participants and examinations
Thirty patients aged 18–34 years (mean age = 25.70 ± 5.26 years) 
who presented to Bina Eye Hospital, Tehran, Iran between 
September and December 2018 with a diagnosis of CI were 
recruited to participate in this cross-sectional study and 
completed the final Persian version of the revised CISS.
All participants underwent complete optometric examinations, 
including the measurement of visual acuity, objective 
and subjective refraction as well as accommodative and 
binocular vision examinations (cover test and measurement 
of the NPC, fusional vergence ranges, and accommodative 
amplitude [AA]) by an experienced optometrist according 
to standard clinical protocols.17 First, uncorrected distance 
visual acuity was measured using a Snellen E-chart at a 
distance of 6 m. Then objective refraction was done using 
the auto-refractometer (KR-8900; Topcon, Tokyo, Japan) 
and refined through retinoscopy (Heine Beta 200 retinoscope, 
Heine Optotechnik, Germany). The best optical correction 
was determined by the subjective refraction, and the best 
corrected distance visual acuity (BCVA) was recorded. In the 
next step, binocular vision and accommodative examinations 
were performed all through the best optical correction. 
The binocular alignment was tested by the unilateral and 
alternating cover tests at 6 m and 40 cm distances, and 
the magnitude of the distance and near heterophorias was 
measured using the alternating cover test and prism bar. 
396  Journal of Current Ophthalmology | Volume 32 | Issue 4 | October-December 2020
Nabovati, et al.: Validation of the Persian CISS questionnaire
The target used for the cover test was a single letter one line 
above the BCVA on the distance and near Snellen charts. To 
measure NPC, an accommodative target (a single character 
one line above BCVA) was slowly moved toward the 
participants along the midline at a constant rate of 5 cm per 
seconds, and they were instructed to keep the target single for 
as long as possible until diplopia occurred or the examiner 
objectively observed a loss of binocularity. At this point, the 
NPC distance was measured from the spectacle plane (if any) 
or the participant’s bony margin of the orbit near the lateral 
canthus using the 50 mm long ruler. Five measurements were 
done to improve test sensitivity, and the mean of the five 
recordings was considered the final NPC. AA was measured 
monocularly using the Donder’s Push-up method. For this 
purpose, an accommodative target (a row of Snellen letters 
one line above BCVA) was slowly brought closer to the 
participant, and he/she was asked to keep a clear view of the 
target and to report when the print became blurred, and he/
she was no longer able to clear it (first sustained blur). At this 
point, the near point of accommodation (NPA) was measured 
from the spectacle plane using the long 50 mm ruler. The NPA 
was measured three times for each eye, and the mean of the 
three recordings was considered the final NPA, which was 
then converted to AA in diopters (D). Positive and negative 
fusional vergence ranges were, respectively, measured using 
base-out and base-in prisms of a prism bar at 6 m and 40 cm 
distances. The target used for the test was a vertical row of 
20/30 letters on the distance and near Snellen charts. The 
prism was placed in front of the participant’s right eye, and 
the prism power was slowly increased in a constant rate of 2 
prism diopters (PD)/s. The participants were asked to fix on 
the target and try to keep it single and clear and to report when 
they noticed first sustained blur and then the double vision. 
At this point, the participant was asked to report the recovery 
of a single vision while decreasing the prism power 2 PD/s. 
With this manner, the amounts of the prism at blur, diplopia, 
and recovery of fusion were recorded as blur/break/recovery 
values. Moreover, an ophthalmologist assessed ocular health 
status by the slit‑lamp biomicroscope (BQ 900, Haag‑Streit, 
Bern, Switzerland) using a +90 lens (Volk Optical, Mentor, 
USA). CI was diagnosed based on the accepted Scheiman and 
Wick’s criteria,1 including: (1) an exophoria at near at least 4 
PD greater than at distance, (2) a receded NPC break (6 cm 
or greater), (3) insufficient PFV at near as a failure of the 
Sheard’s criterion18 (amplitude of PFV at near less than twice 
near exophoria), and (4) a normal monocular AA according to 
the Hofstetter’s formula (measured monocular AA greater than 
minimum AA expected for age suggested by the Hofstetter’s 
formula: 15 − 0.25 × age).19 The exclusion criteria were a 
visual acuity <20/25 in either eye, constant strabismus, a 
near stereoacuity threshold worse than 500 s of arc, manifest 
or latent nystagmus, a history of strabismus, refractive, or 
intraocular surgery, any ocular or systemic disease affecting 
binocular vision or accommodative function, a history of 
ocular trauma, and use of systemic or ocular drugs affecting 
binocular vision and accommodation.
Psychometric assessment of the questionnaire
In this stage, first, the validity of the finalized Persian CISS 
was assessed by a panel of six experts in the field of binocular 
vision. Face validity was assessed based on the aspects of 
fluency (use of meaningful words) and cultural acceptance 
in society using a 6-point Likert scale (very weak, weak, 
moderate, good, very good, best), and a score of ≥4 for each 
item was considered acceptable. Content validity was assessed 
based on three indices of relevancy (the extent to which the item 
of interest can reflect the characteristics of the content under 
study), clarity (appropriateness of the selected items in terms of 
concept and writing style), and comprehensiveness (the ability 
of the instrument to cover all domains related to the topic under 
study). Relevancy and clarity were checked for each item and 
for the whole scale using a 4-point Likert scale (1-undesirable, 
2‑relatively desirable, 3‑desirable, 4‑completely desirable), and 
the Item Content Validity Index (I-CVI) and Scale Content 
Validity Index (S-CVI) were calculated for the above indices 
accordingly. A conservative approach (universal agreement 
approach) was used to determine the I-CVI. In this approach, 
the number of experts who rate the clarity and relevancy of 
each item as desirable or completely desirable is divided 
by the total number of experts. Therefore, the I-CVI value 
is between zero and one (0–100%), and a value of 0.8 or 
higher is considered acceptable.20 The S-CVI for relevancy 
and clarity was calculated by determining the average of 
all I-CVI values (average method). Comprehensiveness 
was only measured at the scale level using a 4-point Likert 
scale (1‑ incomprehensive, 2‑ relatively comprehensive, 3‑ 
comprehensive, and 4- totally comprehensive), and its S-CVI 
was estimated by dividing the number of experts who rated 
the questionnaire as comprehensive or totally comprehensive 
by the total number of experts. Then, the reliability of the 
questionnaire was assessed using internal consistency and 
test-retest reliability analysis. The participants were asked 
to participate in a second administration of the questionnaire 
7–10 days later in order to provide data for the test-retest 
reliability. To assess discriminant validity, CI was categorized 
to three groups of mild (PFV ≥1.50 × near exophoria), 
severe (PFV < near exophoria), and moderate (values in 
between these ranges) based on the severity of clinical 
manifestations according to the Convergence Insufficiency 
Treatment Trial guideline,21 and the mean overall CISS score 
was compared between the three groups.
Statistical analysis
The Statistical Package for the Social Sciences Software 
version 20 (SPSS Inc, Chicago, USA) was used for statistical 
analysis. Descriptive data of clinical characteristics, including 
mean, standard deviation, and range, as well as the data related 
to content validity analysis, including I-CVI and S-CVI values, 
were presented in separate tables. To assess internal consistency, 
Cronbach’s alpha coefficient was calculated at the scale level 
and after removing each item, and values >0.70 were considered 
acceptable.22 Test-retest reliability was measured using interclass 
correlation coefficient (ICC) at the scale level and for each item 
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separately, and values >0.75 were considered acceptable.23 
One-way analysis of variance (ANOVA) was applied to compare 
the overall CISS score between different groups of CI severity. 
A value of P < 0.05 was considered statistically significant.
Ethical issues
The protocol of the study was approved by the Ethics Committee 
of Iran University of Medical Sciences (Registration code: 
IR.IUMS.REC.1397.936). Written informed consent was 
obtained from all participants before the study.
reSultS
Thirty CI patients with a mean age of 25.70 ± 5.26 years (range, 
18–34 years) participated in this study. Half of the participants 
(50%, n = 15) were male. Table 1 presents the distribution of 
clinical characteristics, including near exophoria, NPC, near 
PFV, AA, and CISS score.
On face validity assessment, all items except item 11 had a 
score of equal to or above 4. Therefore, item 11 was modified 
according to the experts’ comments, resulting in a final score 
of 4 for this item. Table 2 shows the results of content validity 
analysis for the relevancy index. According to Table 2, I-CVI 
was above 80% for all items, and S-CVI was 98.88%.
Table 3 presents the results of content validity analysis for 
clarity index. The I-CVI was above 80% for all items, and 
S-CVI was 96.66%.
As for comprehensiveness, five experts assigned a score 
of 4, and one expert gave a score of 3 to the overall 
comprehensiveness of the questionnaire; therefore, the S-CVI 
was 100% for the comprehensiveness index.
The overall Cronbach’s alpha coefficient of the questionnaire was 
0.77, indicating its acceptable internal consistency. The results 
of the internal consistency analysis are presented in Table 4.
The overall ICC was 0.95 (95% confidence interval: 0.90–0.97), 
and the 95% limits of agreement (LOA) were -7.8 to 15.6. The 
mean time between the two administrations of the questionnaire 
was 8.03 ± 0.95 days. The mean difference in the overall 
CISS score between the first and second administrations was 
0.60 ± 1.10 points. Table 5 shows the ICC values for each item. 
According to Table 5, nine items had excellent (above 0.90) and 
six items had good test-retest reliability (0.75–0.90). The highest 
and lowest ICC value was related to item 4 and 14, respectively.
The mean overall CISS score was 26.00 ± 2.00, 29.50 ± 1.22, 
and 33.40 ± 0.70 in mild, moderate, and severe CI groups, 
respectively. Figure 1 shows the mean overall CISS score 
in different CI severity groups. One‑way ANOVA showed a 
significant difference in the mean overall CISS score between 
different levels of CI severity (P = 0.002). According to the 
Bonferroni post hoc test, there was a significant difference 
between mild and severe CI (P = 0.014) and between moderate 
and severe CI groups (P = 0.023), but no significant difference was 
observed between mild and moderate levels of CI (P = 0.548).
dIScuSSIon
As mentioned earlier, the CISS is a standard tool with wide 
applications in clinical practice and research into binocular 
Table 1: Clinical characteristics of the study participants
Index Mean SD Minimum Maximum
Near exophoria (PD) 12.06 1.92 9.00 15.00
NPC (cm) 17.50 3.63 11.50 28.00
Positive fusional 
vergence at near (PD)
9.53 2.76 4.00 16.00
AA (D) 9.75 2.06 6.50 14.50
CISS Score 31.86 3.91 24.00 39.00
PD: Prism diopter, D: Diopter; CISS: Convergence Insufficiency 
Symptom Survey, NPC: Near point of convergence, AA: Accommodative 
amplitude, SD: Standard deviation
Table 2: Content validity analysis for relevancy index
Item Score given by experts (1-6) to relevancy of each item Number of agreements 
observed for score of ≥3
I-CVI S-CVI
1 2 3 4 5 6
1 4 4 4 4 4 4 6 100 98.88
2 4 4 4 4 3 4 6 100
3 4 4 4 4 4 4 6 100
4 4 4 4 4 3 3 6 100
5 4 3 3 3 4 4 6 100
6 3 4 4 4 4 4 6 100
7 4 4 4 4 4 4 6 100
8 4 4 4 4 3 3 6 100
9 3 4 3 4 3 4 6 100
10 4 4 4 4 3 3 6 100
11 4 2 4 3 3 3 5 83.3
12 4 4 4 4 4 4 6 100
13 4 4 4 4 3 4 6 100
14 4 4 4 4 3 3 6 100
15 3 4 3 4 4 4 6 100
I-CVI: Item Content Validity Index, S-CVI: Scale Content Validity Index
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vision disorders.1,4 In this study, we prepared the Persian 
version of this questionnaire and assessed its validity and 
reliability in Iranian CI patients aged 18–34 years. To the best 
of our knowledge, this is the first psychometric assessment of 
the CISS in Iran. The psychometric properties of the original 
version of the revised CISS were assessed by Borsting et al. 
in children aged 9–18 years,11 and by Rouse et al. in young 
adults with the age range 19–30 years,12 and its validity and 
reliability were confirmed in both age groups.
In this study, we comprehensively assessed the content 
validity of the Persian CISS using the approach suggested by 
Lynn,24 which is one of the most comprehensive approaches 
for assessment of content validity that uses the three indices 
of relevancy, clarity, and comprehensiveness in details and 
calculates the CVI for each index separately. As for relevancy, 
the I-CVI of all items was above 80% (I-CVI was 100% for 
14 items and 83.3% for 1 item), and the S‑CVI was estimated 
at 98.88%, indicating the high capability of the Persian CISS 
to reflect the characteristics of the content under study. As for 
clarity, I-CVI was above 80% for all items (100% for 12 items 
and 83.3% for 3 items) with an S‑CVI of 96.66%, indicating the 
appropriateness of all selected items in terms of writing style 
and concept. The S-CVI was 100% for comprehensiveness, 
indicating the excellent capability of the Persian CISS to cover 
all aspects of CI related symptomatology. A characteristic of 
the present study was comprehensive assessment of the content 
validity process. This process was not addressed in details in 
previous studies, and CVI was not reported.
The overall Cronbach’s alpha coefficient was 0.77 in this 
study. Moreover, no item had a negative correlation with the 
overall CISS score, indicating that the Persian version of the 
Table 3: Content validity analysis for clarity index
Item Score given by experts (1-6) to relevancy of each item Number of agreements 
observed for score of ≥3
I-CVI (%) S-CVI (%)
1 2 3 4 5 6
1 4 4 4 4 4 4 6 100 96.66
2 4 4 4 4 3 4 6 100
3 4 4 4 4 4 4 6 100
4 4 4 4 4 3 4 6 100
5 4 2 4 4 4 4 5 83.3
6 4 4 4 4 4 4 6 100
7 4 4 4 4 3 4 6 100
8 4 4 4 4 3 4 6 100
9 3 3 3 4 4 3 6 100
10 4 3 3 2 3 3 5 83.3
11 3 2 3 3 3 3 5 83.3
12 4 4 4 4 4 4 6 100
13 4 4 4 4 3 4 6 100
14 3 4 3 4 3 4 6 100
15 4 4 4 4 4 4 6 100
I-CVI: Item Content Validity Index, S-CVI: Scale Content Validity Index
Table 4: Internal consistency analysis of the Persian 






















CISS: Convergence Insufficiency Symptom Survey
Figure 1: Mean overall Convergence Insufficiency Symptom Survey score 
in different convergence insufficiency severity groups
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CISS had an acceptable internal consistency, and the items 
surveyed were not redundant. Bosrting et al. and Rouse et al. 
reported a Cronbach’s alpha coefficient of 0.92 and 0.84 in 
their similar studies in age groups 9–18 years and 19–30 years, 
respectively.11,12 Although the Cronbach’s alpha coefficient of 
the present study was less than the two above studies, it was 
acceptable, indicating the good homogeneity of the items. It 
should be mentioned that some items like Question 1 (referring 
to eye tiredness), Question 2 (referring to eye discomfort), 
Question 3 (referring to headache), and Question 10 (referring 
to hurting of the eyes) had a stronger correlation with the 
overall CISS score compared to other items, which could 
indicate the higher occurrence of some visual symptoms in CI 
patients. Therefore, these symptoms may be considered more 
specific associated symptoms of CI.
In this study, the test-retest reliability of the Persian version 
of the CISS was assessed using ICC. Evaluation of test-retest 
reliability is important for investigating symptoms changes 
before and after the medical intervention.25 The results 
showed an ICC of 0.95 (95% LOA: −7.8 to 15.6), indicating 
excellent test-retest reliability of the scale. Moreover, 9 
items had excellent and 7 items had good repeatability. 
The mean difference in the overall CISS score between the 
first and second administrations was 0.60 ± 1.10 points, 
indicating minimum bias between these two administrations. 
Borsting et al. reported an ICC of 0.77 (95% LOA: −10.2 
to 12.1) in children under 18 years of age,11 and Rouse 
et al. found an ICC of 0.88 (95% LOA: −9.0 to 7.6) in the 
age group 19–30 years.12 Therefore, the ICC was higher in 
the present study compared to previous studies, especially 
the study conducted in children, indicating the excellent 
test-retest reliability of the Persian CISS. One reason could 
be the older age range of the participants in the present 
study. Studies comparing children’s and adults’ responses 
to surveys have found that adults’ responses are far more 
reliable.12,26
The discriminant validity of the Persian version of the CISS 
was also assessed in this study. The results showed a significant 
difference in the mean overall CISS score between mild and 
severe and also between moderate and severe levels of CI, 
while the difference between mild and moderate CI was not 
statistically significant. Previous studies assessed the ability of 
the CISS to discriminate between CI patients and individuals 
with a normal binocular vision, and a symptom score of 21 
or higher has been found to be significant in adults,10-12 but its 
ability to discriminate between different levels of CI severity 
was not investigated in previous studies. Therefore, it can 
be concluded that the Persian version of the CISS has an 
acceptable discriminant validity and is especially able to detect 
patients with severe stages of CI. Caution should be exercised 
regarding the inability of the questionnaire to discriminate 
between mild and moderate levels of CI because of the small 
number of patients in the mild severity group.
This study had some potential limitations. For example, few 
studies have assessed the psychometric properties of the 
CISS in different ethnic groups, which hinders comparison. 
Moreover, due to the subjective nature of this tool, the 
possibility of information bias cannot be entirely ruled out. 
Moreover, the results were not compared between CI patients 
and healthy subjects. In conclusion, the Persian version of the 
revised CISS is a valid and reliable tool for clinical and research 
applications in the field of binocular vision.
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